scn1a gene Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (1)

Phase 1/2 (1)

Interventional (1)

Stoke Therapeutics, Inc (1)

No (1)

No (1)

Adult (18+) (1)
Pediatric (Under 18) (1)

I am/have/had

I am/have/hadketogenic diet

I am/have/hadepilepsy

I am/have/haddravet syndrome

I am/have/hadscn1a gene

I am/have/hadseizure

I am/have/hadfever

added new label for I am/have/had

more

I am looking for

I am looking fortonic

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 1
For pediatric ages
For adults
Recruiting in 10s
Interventional Study
all
Recruiting

An Open-Label Study to Investigate the Safety of Single Ascending Doses in Children and Adolescents With Dravet Syndrome

Stoke Therapeutics is evaluating the safety and tolerability of single ascending doses of STK-001 in patients with Dravet syndrome. Change in seizure frequency and quality of life will be measured as secondary endpoints in this open-label study.

ketogenic diet

scn1a gene

epilepsy

dravet syndrome

tonic

0 views
05 Aug, 2020

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2025 All rights reserved.